Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Pathologica|November 17, 2025
Shortage of Pathologists: a candid narrativeMassimo Barberis
Pathologica|May 6, 2021
In vitro diagnostic medical device regulation (IVDR): the end of laboratory developed tests (LDT)?Massimo Barberis
Cancers|June 2, 2021
Diagnostic and Predictive Biomarkers in Lung CancerCaterina Fumagalli, Massimo Barberis
Diagnostics (Basel, Switzerland)|September 28, 2021
Breast Cancer HeterogeneityCaterina Fumagalli, Massimo Barberis
Pathologica|July 9, 2024
Precision medicine in ovarian cancer: disparities and inequities in access to predictive biomarkersMassimo Barberis, Nicoletta Colombo, Nicoletta Cerana
Translational Lung Cancer Research|February 11, 2020
Broad-based genomic sequencing in advanced non-small cell lung cancer in the dockCaterina Fumagalli, Elena Guerini-Rocco, Massimo Barberis
Cancers|February 9, 2021
Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)Caterina Fumagalli, Elena Guerini-Rocco, Massimo Barberis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Evaluation of ALK gene status in primary lung adenocarcinoma and matched metastasesAntonio Rossi, Domenico Galetta, Luca Bottiglieri, et al.
Clinical Lung Cancer|April 3, 2018
Letter to the EditorCaterina Fumagalli, Chiara Casadio, Massimo Barberis, et al.
American Journal of Clinical Pathology|March 18, 2008
Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysisMassimo Barberis, Caterina Pellegrini, Maria Cannone, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Pathologica|November 17, 2025
Shortage of Pathologists: a candid narrativeMassimo Barberis
Pathologica|May 6, 2021
In vitro diagnostic medical device regulation (IVDR): the end of laboratory developed tests (LDT)?Massimo Barberis
Cancers|June 2, 2021
Diagnostic and Predictive Biomarkers in Lung CancerCaterina Fumagalli, Massimo Barberis
Diagnostics (Basel, Switzerland)|September 28, 2021
Breast Cancer HeterogeneityCaterina Fumagalli, Massimo Barberis
Pathologica|July 9, 2024
Precision medicine in ovarian cancer: disparities and inequities in access to predictive biomarkersMassimo Barberis, Nicoletta Colombo, Nicoletta Cerana
Translational Lung Cancer Research|February 11, 2020
Broad-based genomic sequencing in advanced non-small cell lung cancer in the dockCaterina Fumagalli, Elena Guerini-Rocco, Massimo Barberis
Cancers|February 9, 2021
Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)Caterina Fumagalli, Elena Guerini-Rocco, Massimo Barberis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Evaluation of ALK gene status in primary lung adenocarcinoma and matched metastasesAntonio Rossi, Domenico Galetta, Luca Bottiglieri, et al.
Clinical Lung Cancer|April 3, 2018
Letter to the EditorCaterina Fumagalli, Chiara Casadio, Massimo Barberis, et al.
American Journal of Clinical Pathology|March 18, 2008
Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysisMassimo Barberis, Caterina Pellegrini, Maria Cannone, et al.
Pageof 17